ImageneBio Inc
35 hedge funds and large institutions have $36.8M invested in ImageneBio Inc in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 8 closing their positions.
37% more capital invested
Capital invested by funds: $26.8M → $36.8M (+$10M)
5.01% more ownership
Funds ownership: 50.27% → 55.28% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 39 → 35 (-4)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$3M |
| 2 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
+$1.59M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$1.09M |
| 4 |
CCC
Cable Car Capital
San Francisco,
California
|
+$152K |
| 5 |
NCNMGF
Nano-Cap New Millennium Growth Fund
Staten Island,
New York
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$388K |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
-$235K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$133K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$75.6K |
| 5 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
-$70.6K |
IMA Hedge Fund Activity: Q2 2026 in Review
35 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q2 2026, worth a combined $36.8M — up 37% from $26.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IMA and 4 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 9 added.
The largest buyer was OrbiMed, adding an estimated $3M. The largest seller was Citadel Advisors, cutting an estimated $388K.
- 35 institutional investors held ImageneBio Inc (IMA) as of Q2 2026, down from 39 in Q1 2026.
- Funds reported $36.8M of ImageneBio Inc stock for Q2 2026, up 37% quarter-over-quarter.
- 4 funds opened new ImageneBio Inc positions in Q2 2026 and 8 closed out, a net change of -4 holders.
- The largest ImageneBio Inc buyer in Q2 2026 was OrbiMed, an estimated $3M added.
- The largest ImageneBio Inc seller in Q2 2026 was Citadel Advisors, an estimated $388K sold.
Based on aggregated 13F filings for Q2 2026.